Prognostic validation of ADV and MoRAL scores for hepatocellular carcinoma recurrence following living donor liver transplantation: a long-term follow-up study

Clinical Transplantation and Research 2026 Open access

Read full text
Authors: Young‐In Yoon, Shin Hwang, Chul‐Soo Ahn, D. H. uk Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Gil‐Chun Park, Woo‐Hyoung Kang, Sung‐Gyu Lee
DOI: 10.4285/ctr.25.0063
Cited by: 0

Abstract

Background: This study compared the prognostic performance of the ADV (α-fetoprotein × des-γ-carboxyprothrombin × tumor volume) and MoRAL (Model to Predict Tumor Recurrence After Liver Transplantation) scores in predicting hepatocellular carcinoma (HCC) tumor recurrence (TR) and overall survival (OS) after living donor liver transplantation (LDLT). Methods: We analyzed 843 patients with HCC who underwent LDLT between 2006 and 2015, assessing TR and OS in relation to the ADV and MoRAL scores. Results: The median ADV and MoRAL scores were 3.7 log and 70.6, respectively, with a moderate correlation between them (r=0.569, P

Fields of Study & Subjects

Organ Transplantation Techniques and Outcomes Hepatocellular Carcinoma Treatment and Prognosis Liver Disease and Transplantation

Publication details

Journal / source
Clinical Transplantation and Research
Volume
40
Issue
2
Pages
243–253
Publication date
9 January 2026
Language
EN